Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Healthcare Medical Devices
Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research labs around the world.


TSXV:NSCI - Post by User

Nanalysis Scientific Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(433)
•••
Post by AwareInvestoron May 20, 2021 7:51am
100 Views
Post# 33236304

Nanalysis Scientific Reports Revenues Of $3.3 Million, Net L

Nanalysis Scientific Reports Revenues Of $3.3 Million, Net L
Nanalysis Scientific Corp released today its first quarter financial results for 2021. The company posted revenues of $3.28 million, versus last year’s figure of $1.52 million. The company recorded a net loss of $467,000 during the quarter.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities